Pharmacological treatment for unipolar psychotic depression - Systematic review and meta-analysis

J Wijkstra*, J Lijmer, FJ Balk, [No Value] Geddes, WA Nolen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

69 Citations (Scopus)

Abstract

Background The optimal pharmacological treatment of unipolar psychotic depression is uncertain.

Aims To compare the clinical effectiveness of pharmacological treatments for patients with unipolar psychotic depression.

Method Systematic review and meta-analysis of randomised controlled trials.

Results Ten trials were included in the review.We found no evidence that the combination of an antidepressant with an antipsychotic is more effective than an antidepressant alone. This combination was statistically more effective than an antipsychotic alone.

Conclusions Antidepressant monotherapy and adding an antipsychotic if the patient does not respond, or starting with the combination of an antidepressant and an antipsychotic, both appear to be appropriate options for patients with unipolar psychotic depression. However, clinically the balance between risks and benefits may suggest the first option should be preferred for many patients. Starting with an antipsychotic alone appears to be inadequate.

Declaration of interest J.W. and WN. are currently conducting a randomised controlled trial in patients with unipolar psychotic depression, which is financially supported by Wyeth and AstraZeneca. These organisations also financially supported the literature search for this review.

Original languageEnglish
Pages (from-to)410-415
Number of pages6
JournalThe British Journal of Psychiatry
Volume188
DOIs
Publication statusPublished - May-2006

Keywords

  • DOUBLE-BLIND
  • CONTROLLED MULTICENTER
  • DELUSIONAL DEPRESSION
  • CLOMIPRAMINE
  • PERPHENAZINE
  • FLUVOXAMINE
  • PAROXETINE
  • IMIPRAMINE
  • PLACEBO

Cite this